prikaz prve stranice dokumenta Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece
  Download
PDF 503.9 KB
master's thesis
Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece
Zagreb: University of Zagreb, School of Medicine, 2018. urn:nbn:hr:105:958079
Klanac, Matea
University of Zagreb
School of Medicine
Department of Pediatrics

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Klanac, M. (2018). Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece (Master's thesis). Zagreb: University of Zagreb, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:958079

Klanac, Matea. "Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece." Master's thesis, University of Zagreb, School of Medicine, 2018. https://urn.nsk.hr/urn:nbn:hr:105:958079

Klanac, Matea. "Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece." Master's thesis, University of Zagreb, School of Medicine, 2018. https://urn.nsk.hr/urn:nbn:hr:105:958079

Klanac, M. (2018). 'Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece', Master's thesis, University of Zagreb, School of Medicine, accessed 30 November 2024, https://urn.nsk.hr/urn:nbn:hr:105:958079

Klanac M. Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece [Master's thesis]. Zagreb: University of Zagreb, School of Medicine; 2018 [cited 2024 November 30] Available at: https://urn.nsk.hr/urn:nbn:hr:105:958079

M. Klanac, "Biološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece", Master's thesis, University of Zagreb, School of Medicine, Zagreb, 2018. Available at: https://urn.nsk.hr/urn:nbn:hr:105:958079

Metadata
TitleBiološka terapija i drugi noviji pristupi liječenju kronične upalne bolesti crijeva u djece
Title (english)Biological therapy and other new therapeutic approaches to inflammatory bowel disease treatment in children
AuthorMatea Klanac
MentorIrena Senečić-Čala (mentor)
Committee memberDuška Tješić-Drinković (predsjednik povjerenstva)
Committee memberMarija Jelušić (član povjerenstva)
Committee memberIrena Senečić-Čala (član povjerenstva)
GranterUniversity of Zagreb
School of Medicine
(Department of Pediatrics)
Zagreb
Defense date and country2018-07-13, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Pediatrics
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract
Kronična upalna bolest crijeva zauzima značajno mjesto u bolestima gastrointestinalnog sustava u djetinjstvu i adolescenciji, a uključuje Crohnovu bolest, ulcerozni kolitis i nerazvrstani kolitis. U otprilike 25% pacijenata s kroničnom upalnom bolesti crijeva, bolest se dijagnosticira prije navršene osamnaeste godine života. Etiologija bolesti je nepoznata, ali se smatra da interakcija okolišnih i genetskih faktora s imunološkim sustavom rezultira neadekvatnim imunološkim odgovorom, s posljedičnom upalom crijevne sluznice. Cilj liječenja je inducirati remisiju bolesti i postići mukozno cijeljenje te svesti nuspojave lijekova na najmanju moguću mjeru. Isključiva enteralna prehrana je učinkovita terapija za indukciju remisije u djece s Crohnovom bolesti i trebala bi biti prva terapijska linija u bolesnika s blažom ili umjereno teškom, nekompliciranom bolesti. Iskorak u liječenju kronične upalne bolesti crijeva napravila je biološka terapija te u novije vrijeme i bioslični lijekovi sa sličnim profilom sigurnosti i učinkovitosti. Biološki lijekovi mogu modificirati tijek bolesti te zaustaviti njezinu progresiju inhibicijom upalne kaskade koja se nalazi u podlozi kronične upalne bolesti crijeva. Pokazali su se učinkovitim u liječenju težih oblika bolesti i bolesti refraktornoj na konvencionalnu terapiju. Noviji pristupi liječenju kronične upalne bolesti crijeva su transplantacija fekalne mikrobiote i antibiotska terapija. Ovi terapijski pristupi mogu utjecati na tijek bolesti promjenom sadržaja crijevnog mikrobioma. Također, noviji pristup je primjena talidomida i transplantacija matičnih stanica. Noviji načini liječenja su se pokazali učinkoviti u indukciji remisije, ali su potrebne dodatne studije za evaluaciju njihove sigurnosti i dugotrajnije učinkovitosti u pedijatrijskoj populaciji.
Abstract (english)
Inflammatory bowel disease occupies a significant place among gastrointestinal diseases in childhood and adolescence and includes Crohn’s disease, ulcerative colitis, and undetermined colitis. About 25% of inflammatory bowel disease patients are diagnosed before the age of 18. The etiology of the disease is unknown, but it is considered that interaction of environmental and genetic factors with the immune system, results in an dysregulated immune response responsible for chronic intestinal inflammation. The treatment goal is to induce clinical remission, to achieve mucosal healing while minimizing the drug’s side effects. Exclusive enteral nutrition is an effective treatment for induction of remission in pediatric Crohn’s disease and should be the first-line treatment in patients with mild and moderate, uncomplicated disease. A step forward in inflammatory disease treatment was achieved with biological therapy and recently with biosimilars that have shown similar safety and efficacy profiles. Biological drugs can alter the disease course and limit its progression through inhibition of the inflammatory process underlying inflammatory bowel disease and are useful in treatment of patients with severe disease or with disease refractory to conventional therapy. New treatment modalities are fecal microbiota transplantation and antibiotic therapy. They may influence the course of the disease by altering the composition of intestinal microbiota. Also new therapeutic approaches are use of thalidomide and stem cell transplantation. New treatment modalities have been effective in remission induction but additional studies to determine their long term efficacy and safety in pediatric population are needed.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:105:958079
Study programmeTitle: Medicine
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2019-01-09 11:12:24